Ed Godber

Ed Godber is the Head of Life Sciences Data and Diagnostics & European Growth at Guardant Health, a position he has held since March 2021. With over 20 years of leadership experience, he focuses on driving business growth and enhancing patient impact through the adoption of disruptive technologies in molecular diagnostics and precision medicine, particularly in Europe.1

Professional Background

• Guardant Health (March 2021 - Present)

  • Leading efforts in the application of molecular diagnostics and data in cancer treatment.

• H-Labs (September 2017 - December 2020)

  • Served as CEO, partnering with technology companies to promote adoption across various sectors.

• iCarbonX PatientsLikeMe (July 2014 - October 2018)

  • Held the position of Executive Vice President, focusing on building businesses around digital data and AI in health.

• GlaxoSmithKline (September 2008 - May 2013)

  • Worked as Senior Vice President for R&D and Commercial Strategy, implementing precision medicine models and addressing market challenges.

Education

• University of York
  • MSc in Health Economics (1993 - 1994)
• London Business School
  • MBA in Business Administration and Management (1999 - 2001)

Ed Godber's expertise lies in the global adoption of innovative technologies and medicines, making significant contributions to the fields of molecular biology and digital health.1